Skip to main content
. 2022 Dec 24;8(12):e12594. doi: 10.1016/j.heliyon.2022.e12594

Table 3.

Comparison results of baseline data for different age groups in delta group.

Variable Age ≤18 years (n = 10) Age 19–44 years (n = 40) Age 45–64 years (n = 33) Age ≥65 years (n = 13) F/H/χ2 P
Sex 4.1568 0.2450
 female 3 (30.00) 24 (60.00) 17 (51.52) 9 (69.23)
 male 7 (70.00) 16 (40.00) 16 (48.48) 4 (30.77)
Classification 0.0076∗
 asymptomatic 1 (10.00) 0 (0.00) 2 (6.06) 1 (7.69)
 mild 7 (70.00) 25 (62.50) 14 (42.42) 2 (15.38)
 moderate 2 (20.00) 15 (37.50)e 17 (51.52) 9 (69.23)
 severe 0 (0.00) 0 (0.00) 0 (0.00) 1 (7.69)
Vaccination <0.0001∗
 No 7 (70.00)abc 1 (2.50) 3 (9.09) 0 (0.00)
 Yes 3 (30.00) 39 (97.50) 30 (90.91) 13 (100.00)
Hematologic
 WBC, ×109/L 7.2022 ± 2.9467 6.0068 ± 1.413 6.2688 ± 2.2544 6.5308 ± 2.6983 0.88 0.4571
 PLT, ×109/L 310.4444 ± 96.6309bc 250.9 ± 73.0963 224.4848 ± 61.2317 192.6154 ± 55.078 5.97 0.0009∗
 NEUT, ×109/L 3.94(2.02–4.39) 3.615(2.75–4.46) 3.36(2.56–4.37) 3.9(2.36–5.21) 0.0144 0.9995
 LYMPH, ×109/L 2.3(2.18–2.65)bc 1.6(1.22–2.065) 1.58(1.27–2.08) 1.62(1–1.74) 11.8874 0.0078∗
 MONO, ×109/L 0.7078 ± 0.1975 0.5823 ± 0.1726 0.6403 ± 0.2539 0.6377 ± 0.242 1.03 0.3841
Coagulation function
 PT, s 12.4444 ± 1.4689 12.0375 ± 1.0392 11.5939 ± 0.9401 11.7077 ± 0.697 2.25 0.0875
 FIB, g/L 2.7378 ± 0.7957 3.0403 ± 0.6101 3.143 ± 1.0312 2.9962 ± 0.7096 0.61 0.6110
 APTT, s 32.6(28.5–35) 28.65(26.4–31.4) 28.1(25.4–29.5) 28.9(28–30.5) 7.4570 0.0587
 TT, s 15.2222 ± 1.8586 13.75 ± 1.3582 14.5394 ± 1.8985 14.1769 ± 2.1222 2.40 0.0731
Liver and renal function
 ALT, U/L 17.25(9.3–85.3) 18.75(11.5–34.35) 23(17.9–30.7) 21(17.7–25.6) 1.8720 0.5994
 AST, U/L 24.9(17–64.65) 16.2(13.85–21.05) 18.9(16.1–26.5) 22.9(17.8–25.9) 9.8124 0.0202∗
 AST/ALT 1.475 ± 0.7998 0.9685 ± 0.3887 0.9485 ± 0.297 1.0962 ± 0.2495 5.7103 0.1266
 TBIL, umol/L 5.25(4.55–9.25) 9.35(6.85–12.55) 10.3(7.6–13.4) 8.1(6–10.7) 6.7904 0.0789
 LDH, U/L 167(133.5–212.5) 131.5(114–144.5)e 152(127–172) 169(151–191) 19.0113 0.0003∗
 BUN, mmol/L 3.95(3.47–5.375) 3.88(3.415–4.52) 4.34(3.71–5.27) 4.48(4.03–5.56) 5.5250 0.1372
 Cr, umol/L 47.5(41–53.55)ab 63.55(58–81.65) 71.8(58.1–78.5) 64.4(53.4–76.8) 11.9213 0.0077∗
 BUN/Cr 0.08(0.07–0.12)a 0.05(0.04–0.07)e 0.07(0.05–0.07) 0.07(0.06–0.08) 17.4821 0.0006∗
 UA, umol/L 347.6875 ± 85.7932 330.835 ± 89.9001 334.8091 ± 99.0559 274.1385 ± 66.9378 1.72 0.1676
Virus shedding time, day 10.4 ± 3.5024 11.8 ± 4.7566 13.1212 ± 4.9671 15.2308 ± 4.0446 2.68 0.0515
Hospitalisation time, day 13.6 ± 3.2042 14.975 ± 3.9645 16.3333 ± 4.4418 17.6923 ± 3.521 2.68 0.0514
ORFlabCT 21.7713 ± 4.8978 21.8006 ± 5.4918 20.8736 ± 5.407 20.2515 ± 6.5323 0.31 0.8176
NCT 19.6038 ± 6.1546 19.1443 ± 6.1276 18.5566 ± 5.7653 17.2415 ± 5.9964 0.39 0.7622
IgG, AU/ml 0.09(0.03–7.13) 6.79(2.105–24.22)d 1.48(0.22–4.88) 2.76(0.72–30.13) 11.9656 0.0075∗
IgM, AU/ml 0.04(0.04–0.06) 0.13(0.045–0.445)d 0.04(0.03–0.12) 0.05(0.04–0.31) 8.7886 0.0322∗
NLR 1.8241(0.8783–2.125) 1.9958(1.5773–3.1924) 1.9234(1.4891–3.4932) 2.5843(1.5029–3.9) 3.9451 0.2675
CRP, mg/L 1.5(0.499–2.36) 2.275(0.499–7.93) 2.56(0.5–7.41) 6.93(2.44–9.07) 5.1480 0.1613
D-D, ug/mL 0.42(0.39–0.47) 0.48(0.43–0.535) 0.5(0.45–0.58) 0.56(0.5–0.64) 8.7015 0.0335∗
CK, U/L 55.17(45.455–82.145) 60.295(45.075–99.63)d 89.92(69.84–161.53) 81.76(57.15–119.38) 8.9571 0.0299∗
Cytokines
 IL-2, pg/ml 1.24(0.99–1.81) 0.95(0.675–1.875) 1.08(0.61–1.83) 0.55(0.4–1.05) 4.5442 0.2084
 IL-4, pg/ml 2.17(1.92–2.67) 1.97(1.505–2.4) 1.76(1.29–2.38) 1.72(1.59–2.63) 2.1922 0.5335
 IL-6, pg/ml 3.38(1.12–4.97) 2.06(0.9–4.32) 2.755(1.54–7.905) 4.5(2.8–7.95) 4.8745 0.1812
 IL-10, pg/ml 4.13(3.02–4.75) 3.99(3.02–5.26) 4.58(2.79–6.6) 4.92(3.45–8.31) 2.1408 0.5437
 TNF-α, pg/ml 4.42(3.5–4.62) 3.165(2.405–3.785) 2.71(2.15–3.71) 2.49(2.21–2.98) 6.9989 0.0719
 IFN-γ, pg/ml 1.23(1.12–1.29) 1.09(0.84–1.725) 1.26(1.07–1.5) 1.6(1.11–1.64) 5.4030 0.1446
Lymphocytes
 Lymph, Cell/ul 2329.4444 ± 594.7926abc 1507.575 ± 522.4229 1513.697 ± 620.797 1334.25 ± 765.9797 5.69 0.0013∗
 T lymph, Cell/ul 1688.7778 ± 438.3742abc 1089.525 ± 417.9818 1050.0606 ± 468.1702 802.9167 ± 341.3584 7.69 0.0001∗
 T4 lymph, Cell/ul 777(655–847)c 615(437–762) 625(416–766) 457(236.5–627) 8.9977 0.0293∗
 T8 lymph, Cell/ul 603(529–735)abc 402(307.5–550) 337(262–487) 317.5(208.5–349.5) 17.2227 0.0006∗
 B lymph, Cell/ul 346(321–501)abc 207.5(133–267) 159(99–256) 137.5(53–216) 16.3686 0.0010∗
 NK lymph, Cell/ul 204(170–259) 182(115.5–264) 254(148–345) 262.5(156.5–486.5) 3.7573 0.2889
 DPT, Cell/ul 22(17–25) 15.5(10.5–26) 19(15–40) 14(9.5–20.5) 6.6659 0.0833

Note: “a” indicates that the difference between the two groups of age≤18years and age 19–44 years are statistically significant; “b” indicates that the difference between the two groups of age≤18 years and age 45–64 years are statistically significant; “c” indicates that the difference between the two groups is age≤18 years and age ≥65 years old is statistically significant; “d” means the difference between the age 19–44 years old and age 45–64 years old groups is statistically significant; "e” means the age 19–44 years old and age ≥65 years old groups are between the two groups The difference is statistically significant; “f” indicates that the difference between the age 45–64 years and age ≥65 years old groups is statistically significant. “∗” indicates that the difference in the four groups are statistically significant.